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Studies show that engaging patients in exercise and/or stress management techniques during hematopoietic
cell transplantation (HCT) improves quality of life. The Blood and Marrow Transplant Clinical Trials Network
tested the efﬁcacy of training patients to engage in self-directed exercise and stress management during HCT.
The study randomized 711 patients at 21 centers to receive 1 of 4 training interventions before HCT: a self-
directed exercise program, a self-administered stress management program, both, or neither. Participants
completed self-reported assessments at enrollment and up to 180 days after HCT. Randomization was
stratiﬁed by center and transplant type. There were no differences in the primary endpoints of the Physical
Component Summary and Mental Component Summary scales of the Medical Outcomes Study Short Form 36
at day þ100 among the groups, based on an intention-to-treat analysis. There also were no differences in
overall survival, days of hospitalization through day þ100 post-HCT, or in other patient-reported outcomes,
including treatment-related distress, sleep quality, pain, and nausea. Patients randomized to training in stress
management reported more use of those techniques, but patients randomized to training in exercise did not
report more physical activity. Although other studies have reported efﬁcacy of more intensive interventions,
brief training in an easy-to-disseminate format for either self-directed exercise or stress management was not
effective in our trial.
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14.05.027INTRODUCTION
The adverse effects of hematopoietic cell transplantation
(HCT) on short and long-term quality of life (QoL) are well
documented [1]. Patients experience numerous adverse
symptoms, such as nausea, fatigue, and sleep disturbance,
accompanied by declines in physical and mental well being.
Although most longitudinal studies have found that the
majority of patients return to baseline functioning, it may
take years to reach this goal [2-7]. Currently, there are
no national guidelines on the use of exercise or stressTransplantation.
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ters generally do not have the resources to provide intensive
or ongoing supervision in exercise and stress management
techniques to their patients.
Previous single-institution studies, including some ran-
domized controlled trials (RCTs), showed that engagement
in exercise [8-25] and stress management [26-31] during or
after HCT improved many outcomes in HCT recipients. The
tested interventions varied from active, guided sessions to
home-based interventions. Outcomes included self-reported
measures such as QoL, mood, fatigue, and distress, as well as
objective measures of functional status, strength, stamina,
hospital days, and survival. In these studies, stress mana-
gement interventions primarily improved mental health
outcomes and nausea, whereas relaxation and imagery were
associated with less pain after HCT [30]. The impact of ex-
ercise interventions was more variable; most studies and
meta-analyses reported physical health beneﬁts [20,32],
whereas other also reported mental health beneﬁts [24,33].
In RCTs in patients with solid tumors, stress management
training has been shown to improve both mental and phys-
ical health [27]. Combining stress management and exercise
training is feasible and well tolerated by oncology patients
[31,34,35], and a recent RCT found that the combination was
more effective than usual care in improving anxiety and
depression over the course of outpatient chemotherapy [28].
The present study was designed to test whether a brief
training session to encourage use of a self-administered
stress management program and/or self-directed exercise
program would improve both the physical and mental well
being of recipients of autologous HCT and allogeneic HCT
compared with usual care.
METHODS
Participants
A total of 711 patients at 21 US centers were enrolled between January
2011 and June 2012 through the Blood andMarrow Transplant Clinical Trials
Network (BMT CTN 0902). Inclusion criteria were age 18 years, ability to
speak and read English, ability to exercise at low to moderate intensity (as
judged by self-reported ability to walk up 1 ﬂight of stairs), no requirement
for supplemental oxygen, and autologous or allogeneic HCT planned within
6 weeks. Exclusion criteria were orthopedic, neurologic, or other problems
that prevented safe ambulation or protocol adherence, participation in
another clinical trial with QoL or functional status as a primary endpoint,
planned anticancer therapies other than tyrosine kinase inhibitors or rit-
uximab within 100 days after HCT, planned donor lymphocyte infusion
within 100 days after HCT, and planned tandem transplantation.
Study Design
The study was designed as a phase III multicenter RCT. After enrollment
and baseline self-reported information was collected, the patients were
randomized using a factorial design to 4 groups: exercise training, stress
management training, the combination of exercise and stress management
training, and usual care. The intervention was provided before HCT as a 20-
minute introduction to the self-directed program. Trained site personnel
served as the interventionists, who reviewed a pamphlet summarizing the
main points of the self-directed program and gave the patients a DVD
reinforcing the program. Patients received a diary in which to track partic-
ipation in exercise and/or stress management. In addition, the in-
terventionists reviewed the goals for use of the program, proper technique,
identiﬁcation of barriers to engagement in exercise or stress management,
and plans to overcome these barriers. The exercise component also included
calculation of target heart rate and provision of a pedometer. The stress
management component also included provision of a relaxation CD.
In all of the intervention groups, the interventionists recontacted pa-
tients at 30 and 60 days after HCT to review the training goals, discuss
barriers, and provide encouragement. To ensure ﬁdelity of the delivered
intervention, the ﬁrst 2 patient interactions of each interventionist were
audiotaped and reviewed centrally. Ten percent of subsequent interactions
were observed by another study person at the center, to ensure that critical
material was delivered consistently. All 3 intervention groups and the usualcare group received a 45-minute DVD presenting general information about
HCT, which included very brief and nonspeciﬁc comments about keeping
active and minimizing stress during transplantation [36].
The exercise goal was walking 3 to 5 times a week for at least 20 to
30 minutes at 50% to 75% of estimated heart rate reserve, consistent with
guidelines for exercise in cancer patients developed by the American College
of Sports Medicine [37]. The stress management goal targeted paced
abdominal breathing [38], progressive muscle relaxation with guided
imagery [39], and coping self-statements [40] to decrease and manage
stress [41].
The full protocol is available on the BMT CTN Web site
(www.bmtctn.net). The research protocol was approved by a protocol re-
view committee appointed by the National Heart, Lung and Blood Institute
(NHLBI) and by local Institutional Review Boards or Ethics Committees. All
participants provided written informed consent. An NHLBI-appointed Data
and Safety Monitoring Committee provided oversight. This study is regis-
tered with ClinicalTrials.gov (NCT01278927). All patient materials used in
this trial are available through the Be The Match organization at www.be-
thematch.org. Readers interested in additional details of the interventions,
including training scripts, should contact the BMT CTN.
Data Collection Instruments
Participants completed self-reported assessments at enrollment and 30,
60,100 and 180 days after HCT. Instruments included: (1) Medical Outcomes
Study Short Form 36 (SF-36), version 2.0, a 36-item, generic multidimen-
sional QoL measure with 2 summary domains, a Physical Component
Summary (PCS) scale and a Mental Component Summary (MCS) scale, and 8
subscales, including a 2-item Bodily Pain subscale; (2) Cancer and Treatment
Distress (CTXD) [7,42], a 27-item measure of distress with subscales of
Uncertainty, Health Burden, Family Strain, Identity, and Managing the
Medical System, as well as distress interferencewith function; (3) Pittsburgh
Sleep Quality Index (PSQI) [43-45], a 7-item measure of sleep patterns and
difﬁculties such as sleep quality, sleep latency, sleep efﬁciency, and use of
sleeping medications; and (4) nausea, measured by 2 items formatted
similar to the SF36 Bodily Pain subscale. The age- and sex-adjusted norm for
the PCS and MCS scales is 50 points, with a standard deviation of 10 points.
Higher scores indicate better QoL. For the CTXD, PSQI, and nausea, higher
scores indicate greater symptom burden. Other secondary outcomes
included days of hospitalizationwithin the ﬁrst 100 days after graft infusion
and survival.
Measures of adherence were collected to evaluate whether patients
were engaging in the self-administered programs. The Leisure Score Index
(LSI) of the Godin Leisure-Time Exercise Questionnaire [46] was used to
measure physical activity [47]. Participation in stress management activities in
the previous week was measured with a 5-item Stress-Reduction Checklist
[27]. Participants’ impressions of perceived program effectiveness, program
importance, and skill of the interventionist were also rated on 7-point Likert
scales.
Statistical Analyses
The co-primary endpoints were the SF-36 PCS andMCS at dayþ100. The
study was designed to have 85% power to detect a clinically meaningful
difference of 0.5 SD in the exercise or stress management groups on each of
the 2 endpoints, maintaining an overall type I error rate of 0.05. The sample
size was inﬂated to adjust for a 5% failure to undergo HCT, 10% death before
day þ100, and 15% missing day þ100 self-reported data from surviving
participants, resulting in a target accrual of 700 patients. Randomizationwas
stratiﬁed by center and transplant type (autologous, myeloablative alloge-
neic, or nonmyeloablative allogeneic).
The primary analysis was on an intention-to-treat basis that includes all
randomized patients classiﬁed according to their assigned treatment. The
exercise groups (exercise-only arm and exercise/stress management arm)
were compared with the no exercise groups (usual care arm and stress
management arm). The stress management analysis was conducted analo-
gously. Patients who died within 100 days of HCT were assigned PCS and
MCS scores of 0 (lower than the lowest observed score), and those alive at
the last follow-up with missing PCS and MCS were assigned scores of 5
(lower than the lowest observed score but higher than the score assigned to
patients who died within the ﬁrst 100 days). Day þ100 PCS and MCS were
compared without adjustment for baseline scores or other clinical charac-
teristics using the Mann-Whitney test, a nonparametric test that tests only
the ranks of the scores rather than the actual scores. Each test was con-
ducted at the 0.025 signiﬁcance level to adjust for the co-primary endpoints
for each factor.
Secondary analyses examining main effects for PCS and MCS in survi-
vors were conducted using multiple linear regression, adjusting for base-
line assessments and other covariates associated with the outcome.
Number of days alive and out of the hospital through day þ100 post-HCT
Table 1
Characteristics of the Study Population at Enrollment (n ¼ 711)
Variable Standard Exercise Stress
Management
Exercise/Stress
Management
P Value
Number of patients 175 180 178 178
Number of centers 19 19 20 20
Age at transplantation, yr .38
Median (range) 55 (19-76) 58 (20-76) 58 (20-75) 57 (18-75)
40, n (%) 27 (15) 26 (14) 21 (12) 26 (15)
40 to <65, n (%) 111 (63) 105 (58) 123 (69) 118 (66)
65, n (%) 37 (21) 49 (27) 34 (19) 34 (19)
Ethnicity, n (%) .41
Hispanic or Latino 6 (3) 7 (4) 11 (6) 11 (6)
Not Hispanic or Latino 167 (95) 172 (96) 167 (94) 167 (94)
Unknown/not applicable 2 (1) 1 (<1) 0 0
Race, n (%) .45
American Indian/Alaskan Native 0 0 1 (<1) 0
Asian 2 (1) 3 (2) 4 (2) 2 (1)
Hawaiian/Paciﬁc Islander 1 (<1) 1 (<1) 0 1 (<1)
Black or African American 16 (9) 14 (8) 17 (10) 13 (7)
White 152 (87) 162 (90) 152 (85) 160 (90)
More than one race 3 (2) 0 1 (<1) 2 (1)
Other/unknown 1 (<1) 0 4 (2) 0
Recipient sex, n (%) .37
Male 93 (53) 112 (62) 100 (56) 100 (56)
Female 82 (47) 68 (38) 78 (44) 78 (44)
Marital status, n (%) .16
Married/living with partner 122 (70) 145 (81) 137 (77) 125 (70)
Single, never married 28 (16) 12 (7) 18 (10) 26 (15)
Separated, divorced 17 (10) 16 (9) 16 (9) 24 (13)
Widowed 6 (3) 6 (3) 4 (2) 2 (1)
Missing 2 (1) 1 (<1) 3 (2) 1 (<1)
Education, n (%) .50
Grade school 2 (1) 0 0 0
High school 36 (21) 33 (18) 37 (21) 35 (20)
College graduate 108 (62) 114 (63) 101 (57) 100 (56)
Postgraduate 28 (16) 32 (18) 38 (21) 42 (24)
Missing 1 (<1) 1 (<1) 2 (1) 1 (<1)
Employment status, n (%) .56
Not employed 98 (56) 99 (55) 89 (50) 97 (54)
Employed 77 (44) 80 (44) 87 (49) 81 (46)
Missing 0 1 (<1) 2 (1) 0
Income, n (%) .31
<$15,000 9 (5) 15 (8) 7 (4) 10 (6)
$15,000-$24,999 14 (8) 10 (6) 17 (10) 10 (6)
$25,000-$49,999 40 (23) 25 (14) 27 (15) 41 (23)
$50,000-$74,999 34 (19) 47 (26) 32 (18) 36 (20)
$75,000-$99,999 21 (12) 24 (13) 30 (17) 25 (14)
$100,000þ 43 (25) 50 (28) 53 (30) 47 (26)
Missing 14 (8) 9 (5) 12 (7) 9 (5)
Karnofsky Performance Score, %, n (%) .35
90 102 (58) 112 (62) 111 (62) 94 (53)
70-80 68 (39) 65 (36) 64 (36) 76 (43)
50-60 4 (2) 2 (1) 1 (<1) 3 (2)
Missing/not done 1 (<1) 1 (<1) 2 (1) 5 (3)
Body mass index .16
Median (range) 28 (19-52) 27 (16-54) 28 (18-56) 29 (19-52)
Underweight (<18.5), n (%) 0 3 (2) 1 (<1) 0
Normal (18.5-24.9), n (%) 51 (29) 49 (27) 38 (21) 40 (22)
Overweight (25-29.9), n (%) 66 (38) 67 (37) 64 (36) 60 (34)
Obese (30), n (%) 57 (33) 60 (33) 74 (42) 74 (42)
Missing, n (%) 1 (<1) 1 (<1) 1 (<1) 4 (2)
Disease/disease status, n (%) .83
Acute myelogenous/lymphoblastic leukemia 42 (24) 42 (23) 47 (26) 40 (22)
Chronic myelogenous leukemia 2 (1) 5 (3) 5 (3) 2 (1)
Myelodysplastic/myeloproliferative syndrome 13 (7) 19 (11) 16 (9) 15 (8)
Multiple myeloma/plasma cell dyscrasia 57 (33) 50 (28) 43 (24) 44 (25)
Lymphoma 50 (29) 54 (30) 60 (34) 66 (37)
Chronic lymphocytic leukemia 7 (4) 5 (3) 4 (2) 6 (3)
Other disease 3 (2) 4 (2) 3 (2) 2 (1)
Missing 1 (<1) 1 (<1) 0 3 (2)
Previous transplantation, n (%) .79
No 156 (89) 166 (92) 162 (91) 161 (90)
Yes 19 (11) 14 (8) 16 (9) 17 (10)
(Continued on next page)
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Table 1
(continued)
Variable Standard Exercise Stress
Management
Exercise/Stress
Management
P Value
Previous cytotoxic chemotherapy, n (%) .79
No 24 (14) 26 (14) 27 (15) 21 (12)
Yes 142 (81) 142 (79) 135 (76) 144 (81)
Missing 9 (5) 12 (7) 16 (9) 13 (7)
Patient CMV status .52
Positive 101 (58) 104 (58) 101 (57) 88 (49)
Negative 73 (42) 75 (42) 77 (43) 88 (49)
Missing 1 (<1) 1 (<1) 0 2 (1)
Transplant type .91
Allogeneic 86 (49) 89 (49) 90 (51) 86 (48)
Autologous 89 (51) 90 (50) 88 (49) 91 (51)
Missing 0 1 (<1) 0 1 (<1)
In allogenieic HCT, conditioning intensity .94
Myeloablative 41 (48) 40 (45) 40 (44) 37 (43)
Nonmyeloablative 45 (52) 49 (55) 50 (56) 49 (57)
Baseline intervention delivered .81
No 2 (1) 3 (2) 3 (2) 3 (2)
Yes 173 (99) 175 (97) 172 (97) 173 (97)
Missing 0 2 (1) 3 (2) 2 (1)
Baseline SF36 PCS, median (range) 42.1 (13.5-61.3) 42.8 (14.4-64.9) 44.4 (16.5-62.2) 42.9 (14.0-62.5) .34
Baseline SF36 MCS, median (range) 52.9 (7.8-67.2) 51.7 (16.7-74.0) 52.2 (11.6-66.1) 52.4 (18.9-69.8) .77
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log-rank tests. Three sensitivity analyses for handling missing assessments
were conducted for the day þ100 outcomes conditional on being alive: all
available data, multiple imputation to impute missing day þ100 values, and
an inverse probability-weighted generalized estimating equations model to
account for missing data [48]. Available data for PCS, MCS, pain, sleep
quality, nausea, and CTXD at day þ100 were evaluated using linear regres-
sion models adjusting for baseline scores. Because of multiple testing, a P
value <.01 was considered signiﬁcant.
Exploratory subgroup analyses were conducted to look for a differential
treatment effect on day þ100 PCS and MCS scores according to autologous
HCT versus myeloablative allogeneic HCT versus nonmyeloablative alloge-
neic HCT (because this was a stratiﬁcation factor) or in groups with high
versus low baseline PCS or MCS or high versus low engagement in exercise
and stress management, dichotomized at the median. These analyses
adjusted for baseline PCS and MCS scores. Statistical analyses were per-
formed using SAS/STAT version 9.3 (SAS Institute, Cary, NC).
RESULTS
Participant Characteristics
The study included 711 participants, distributed evenly
between allogeneic and autologous HCT recipients. Partici-
pants were enrolled a median of 7 days (interquartile range,
3 to 13 days) before HCT. The groups were well balanced for
baseline characteristics (Table 1). At enrollment, only 2.6%
met the American College of Sports Medicine guidelines of
150 minutes of moderate intensity activity per week as
measured by the LSI. Approximately 60% of participants had
a Karnofsky Performance Status of 90% or greater. Two-thirds
(67%) used at least 1 of the stressmanagement techniques; 53%
used self-talk to help coping, 41% used self-guided relaxation,
34% used deep breathing,12% listened to relaxation audiotapes,
and 4% watched videos/DVDs about managing stress.
Five participants (0.7%) did not undergo HCT, 21 (2.9%)
did not attend a training session, and 2 (<0.1%) received
incorrect training. These patients were analyzed with their
assigned groups for the intention-to-treat analysis. Addi-
tional attritionwas due to death and failure to return surveys
(Figure 1). Survival and missing data rates were similar
across the study arms. The primary cause of death within the
ﬁrst 6 months in all treatment arms was relapse.
Primary Endpoint: Day þ100 PCS and MCS
There were no differences in the primary endpoints of
PCS and MCS at day þ100 between the exercise and noexercise groups or between the stress management and no
stress management groups (P > .14 for all; Table 2).
Secondary Endpoints: Day þ100 and Day 180
Results of analyses conditional on being alive and using
only available data or accounting for missing data by mul-
tiple imputation or by inverse probability of censoring
weighted generalized estimating equations [48] led to the
same conclusion as the primary analyses for PCS and MCS.
There were no differences in day þ100 CTXD, sleep quality,
pain, and nausea (Table 3) or in the SF-36 subscales (data not
shown). There was no interaction between the 2 interven-
tions. No differences were observed in overall survival at
1 year (P¼ .15) or number of days alive and out of the hospital
through day þ100 post-HCT (P ¼ .42). After adjusting for
baseline scores, there was no association between assigned
group and day þ180 patient-reported outcomes, including
PCS, MCS, cancer and treatment distress, sleep quality, pain,
and nausea (data not shown).
Intervention Credibility and Adherence
Participants receiving exercise training thought it would
improve their QoL and would want the training to be avail-
able to other patients (P < .0001), whereas this was not the
casewith the stressmanagement training. Training in exercise
or stress management had no effect on self-reported exercise
activity at day þ30, day þ60, and day þ100, but physical ac-
tivity was higher at day þ180 (P ¼ .04) in patients assigned to
exercise training after adjusting for baseline exercise activity.
Assignment to exercise training had no effect on self-reported
stress management activity after adjusting for baseline stress
management activity, but assignment to stress management
training was strongly associated with an increase in stress
management activity at all time points (P < .0003).
Exploratory Analyses
We analyzed predictors of better QoL at day þ100 using
multiple regression and multiple imputation for missing
values. Higher PCS at day þ100 was associated with higher
PCS at enrollment, being employed, and undergoing autol-
ogous HCT rather than myeloablative allogeneic HCT or
reduced-intensity/nonmyeloablative allogeneic HCT. There
Figure 1. CONSORT diagram
P.B. Jacobsen et al. / Biol Blood Marrow Transplant 20 (2014) 1530e15361534was no difference between the 2 types of allogeneic condi-
tioning intensities. Higher MCS at day þ100 was associated
with higher MCS at enrollment and higher income (Table 4).
To support future research directions in the HCT popu-
lation, we explored whether speciﬁed subgroups might have
beneﬁted more than others from the training interventions.
No beneﬁts were seen in subgroups of autologous HCT versus
allogeneic HCT, lower versus higher baseline PCS or MCS
scores, or lower versus higher baseline engagement in
exercise or stress management (data not shown).
DISCUSSION
Despite the fact that meta-analyses of RCTs of exercise
and stress management training suggest beneﬁts for HCT
recipients [32,33], our large multicenter RCT did not
demonstrate any measurable beneﬁt from a brief training
session to encourage patients to use self-directed exercise or
stress management during HCT. There are several possible
explanations for our ﬁndings. First, our brief training
sessions might have lacked sufﬁcient intensity to promote
adoption of exercise, as suggested by the lack of differences
at days þ30, þ60, and þ100. Perhaps the peritransplantation
period, in the midst of intensive medical preparation for HCT
and the subsequent acute toxicities of HCT, was too intrin-
sically stressful and physically limiting to allow patientsTable 2
Primary Analyses: Intention-to-Treat Analysis of Day þ100 PCS and MCS
Day þ100 SF36 Score P Value
Exercise (n ¼ 358),
Median (IQR)
No Exercise (n ¼ 353),
Median (IQR)
PCS 37.5 (19.7-46.7) 39.7 (27.1-47.7) .14
MCS 49.4 (27.3-57.7) 50.1 (34.2-57.8) .33
Stress management
(n ¼ 356), median (IQR)
No stress management
(n ¼ 355), median (IQR)
PCS 37.8 (22.1-46.6) 39.7 (25.7-47.9) .21
MCS 50.7 (31.0-58.2) 49.1 (30.5-56.8) .30
IQR indicates interquartile range.to beneﬁt from a low-intensity, self-administered exercise
program. Similarly, although patients who received stress
management training reported great use of stress manage-
ment techniques, these strategies might have been inade-
quate to ameliorate the negative physical and emotional
effects of HCT.
A second possibility is that the self-reporting measures
used in this study were not sufﬁciently sensitive to detect
intervention effects. One randomized study in HCT recipients
reported differences in some objective measures of strength
and endurance, but not in self-reported symptoms or QoL,
suggesting that the detected functional differences were not
clinically meaningful [49], or that these measures are not
reﬂective of physical functioning [50]. The SF-36 PCS and
MCS are global subscales that might not capture improved
strength or endurance; however, the CTXD was developed
speciﬁcally to measure distress related to HCT, and it has
shown sensitivity to change over the course of treatment
[7,42]. Measuring the primary outcome at day þ100 may
have been too early, if physical functioning is dominated
by transplantation toxicity at that time, regardless of
whether participants were engaging in exercise or stress
management.
A third possibility is that broad application of the inter-
vention obscured effects that would have been observed in
some vulnerable or more adherent subgroups. Two trials in
HCT suggested the greatest beneﬁts in the less-ﬁt group
[14,51]. However, we failed to ﬁnd potential beneﬁciaries
in exploratory analyses, including those undergoing diffe-
rent types of transplantations or those with lower PCS and
MCS scores.
It is unlikely that our negative results can be attributed to
sufﬁcient participation in exercise and stress management
under usual care, or that patients randomized to usual care
beneﬁtted from the training being delivered to other pa-
tients. Although it is common for transplantation providers
to encourage patients to stay as active as possible and
minimize stress during HCT, exercise engagement was low in
all groups, including the usual care group. There was no
Table 3
Secondary Analyses: Available Data for Secondary Endpoints at Day þ100 Adjusted for Baseline Score, According to Treatment Arm
Median Scores Exercise Stress
Management
Exercise þ Stress
Management
Usual Care P1 P2 P3 Overall P
Value
PCS 42.2 41.8 40.6 42.5 .62 .18 .13 .39
MCS 50.8 52.4 52.1 50.4 .23 .30 .16 .50
Cancer and Treatment
Distress (CTXD)
0.96 0.88 1.04 0.94 .54 .31 .51 .37
Sleep quality (PSQI) 4.55 3.49 4.44 4.02 .34 .14 .41 .06
Pain 67.78 71.55 67.96 68.19 .76 .56 .81 .84
Nausea 2.74 2.63 2.80 2.85 .71 .31 .72 .79
P1, comparison of exercise versus usual care; P2, comparison of stress management versus usual care; P3, comparison of exercise and stress management versus
usual care.
PCS: age- and sex-adjusted mean ¼ 50; higher score reﬂects better physical functioning.
MCS: age- and sex-adjusted mean ¼ 50; higher score reﬂects better mental functioning.
CTXD: higher score reﬂects more distress.
PSQI: higher score reﬂects worse sleep quality.
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ticipants who did not receive the stress management training.
Some limitations of this study should be noted. We pur-
posefully did not test an intensive guided exercise or stress
management program, because many transplantation pro-
grams do not have the resources to provide this degree of
supervision [52]. Studies that provided more intensive
training generally found greater differences [24], although a
Cochrane review suggested that a self-directed component is
important for maintaining behavior changes beyond the
intervention period [53]. In addition, we did not collect
process information or patient-reported insights to under-
stand why the training interventions were not successful.
The results of the present study suggest several directions
for future research on improving QoL through stress man-
agement and exercise training for HCT recipients. First, in-
terventions may be more effective if introduced sufﬁciently
early before HCT to allow patients to incorporate these
practices into their routines, or after HCT when patients have
recovered from short-term treatment side effects, as sug-
gested by our ﬁnding showing that intervention assignment
had no effects on exercise activity until day þ180. Second, it
is also possible that targeting patients with a demonstrated
need for increased exercise (ie, sedentary individuals) orTable 4
Predictors of PCS and MCS at Day þ100 with Multiple Imputation
Effect Level n Estimate (95% CI) P Value
PCS (n ¼ 642)
Exercise No 324 0
Yes 318 0.15 (1.88 to 1.57) .86
Stress
management
No 327 0
Yes 315 1.44 (2.94 to 0.06) .06
Baseline PCS 0.42 (0.33 to 0.51) <.0001
Employed No 343 0
Yes 299 1.73 (0.18 to 3.29) .03
Transplant typey Autologous 338 0 .0003*
MA 134 4.48 (6.71 to 2.24) .0002
NMA 170 3.43 (5.34 to 1.53) .0005
MCS (n ¼ 606)
Exercise No 304 0
Yes 302 0.48 (1.12 to 2.08) .56
Stress
management
No 306 0
Yes 300 0.71 (1.12 to 2.53) .44
Baseline MCS 0.37 (0.29 to 0.45) <.0001
Income <$50,000 201 0
$50,000 405 2.55 (0.59 to 4.42) .01
* Overall P value.
y Myeloablative allogeneic (MA) versus nonmyeloablative allogeneic
(NMA): estimate, 1.04 (95% CI, 3.93 to 1.85); P ¼ .46.stress management (ie, distressed individuals) would be
more effective [51,54]. Third, the intervention may be more
effective if more intensive or personalized. Internet-based
strategies are one approach to increasing the frequency of
contact with participants and tailoring programs to speciﬁc
patient needs without the need to add local professional
resources [55,56]. Other approaches, such as exercise in
shorter and more intensive sessions, supervised group ex-
ercise, use of ancillary motivating devices (eg, FitBit, Nike,
Jawbone), or other forms of exercise (eg, reclining bicycles),
might be more effective in HCT recipients. These methods
require more intensive training and follow-up but may be
necessary to achieve change. Given the unexpected results of
the present study, the importance of conducting rigorous
evaluations to determine the efﬁcacy of other potential in-
terventions is clear.
In conclusion, our study does not support a beneﬁt from
including a single brief instruction in exercise or stress
management for all HCT recipients to reduce distress or
improve physical or mental functioning during transplan-
tation and recovery. Although this brief intervention does
not require further testing in our estimation, other methods
that may improve physical and mental health outcomes
while remaining feasible in cost and patient energy re-
quirements merit evaluation.ACKNOWLEDGMENTS
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